{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T14:35:36Z","timestamp":1777905336658,"version":"3.51.4"},"reference-count":49,"publisher":"Cambridge University Press (CUP)","issue":"3","license":[{"start":{"date-parts":[[2015,1,2]],"date-time":"2015-01-02T00:00:00Z","timestamp":1420156800000},"content-version":"unspecified","delay-in-days":7612,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infect. Control Hosp. Epidemiol."],"published-print":{"date-parts":[[1994,3]]},"abstract":"Abstract<\/jats:title>\n \n Objective:<\/jats:title>\n The objectives of this quality standard are 1) to provide an implementation mechanism that will facilitate the reliable administration of prophylactic antimicrobial agents to patients undergoing operative procedures in which such a practice is judged to be beneficial and 2) to provide a guideline that will help local hospital committees formulate policies and set up mechanisms for their implementation. Although standards in the medical literature spell out recommendations for specific procedures, agents, schedules, and doses, other reports document that these standards frequently are not followed in practice.<\/jats:p>\n <\/jats:sec>\n \n Options:<\/jats:title>\n We have specified the procedures in which the administration of prophylactic antimicrobial agents has been shown to be beneficial, those in which this practice is widely thought to be beneficial but in which compelling evidence is lacking, and those in which this practice is controversial. We have examined the evidence regarding the optimal timing of drug administration, the optimal dose, and the optimal duration of prophylaxis.<\/jats:p>\n <\/jats:sec>\n \n Outcomes:<\/jats:title>\n The intended outcome is more uniform and reliable administration of prophylactic antibiotics in those circumstances where their value has been demonstrated or their use has been judged by the local practicing medical community to be desirable. The result should be a reduction in rates of postoperative wound infection with a limitation on the quantities of antimicrobial agents used in circumstances where they are not likely to help.<\/jats:p>\n <\/jats:sec>\n \n Evidence:<\/jats:title>\n Many prospective, randomized, controlled trials comparing placebo with antibiotic and comparing one antibiotic with another have been conducted. In addition, some trials have compared the efficacy of different doses or methods of administration. Other papers have reported on the apparent efficacy of administration at different times and on actual practice in specific communities. Only a small group of relevant articles found through 1993 are cited herein. When authoritative reviews are available, these-rather than an exhaustive list of original references-are cited.<\/jats:p>\n <\/jats:sec>\n \n Values:<\/jats:title>\n We assumed that reducing rates of postoperative infection was valuable but that reducing the total amount of antimicrobial agents employed was also worthwhile. The cost of and morbidity attributable to postoperative wound infections should be weighed against the cost and potential morbidity associated with excessive use of antimicrobial agents.<\/jats:p>\n <\/jats:sec>\n \n Benefits, Harms, and Costs:<\/jats:title>\n More reliable administration of antimicrobial agents according to recognized guidelines should prevent some postoperative wound infections while lowering the total quantity of these drugs used. No harms are anticipated. The costs involved are those of the efforts needed on a local basis to design and implement the mechanism that supports uniform and reliable administration of prophylactic antibiotics.<\/jats:p>\n <\/jats:sec>\n \n Recommendations:<\/jats:title>\n All patients for whom prophylactic antimicrobial agents are recommended should receive them. The agents given should be appropriate in light of published guidelines. A short duration of prophylaxis (usually < 24 hours) is recommended.<\/jats:p>\n <\/jats:sec>\n \n Validation:<\/jats:title>\n More than 50 experts in infectious disease and 10 experts in surgical infectious disease and surgical subspecialties reviewed the standard. In addition, the methods for its implementation were reviewed by the American Society of Hospital Pharmacists.<\/jats:p>\n <\/jats:sec>\n \n Sponsors:<\/jats:title>\n The Quality Standards Subcommittee of the Clinical Affairs Committee of the Infectious Disease Society of America (IDSA) developed the standard. The subcommittee was composed of representatives of the IDSA (Drs. Gross and McGowan), the Society for Hospital Epidemiology of America (Dr. Wenzel), the Surgical Infection Society (Dr. Dellinger), the Pediatric Infectious Disease Society (Dr. Krause), the Centers for Disease Control and Prevention (Dr. Martone), the Obstetrics and Gynecology Infectious Diseases Society (Dr. Sweet), and the Association of Practitioners of Infection Control (Ms. Barrett). Funding was provided by the IDSA and the other cooperating organizations. The standard is endorsed by the IDSA.<\/jats:p>\n <\/jats:sec>","DOI":"10.1086\/646887","type":"journal-article","created":{"date-parts":[[2009,9,3]],"date-time":"2009-09-03T13:55:44Z","timestamp":1251986144000},"page":"182-188","source":"Crossref","is-referenced-by-count":168,"title":["Quality Standard for Antimicrobial Prophylaxis in Surgical Procedures"],"prefix":"10.1017","volume":"15","author":[{"given":"E. Patchen","family":"Dellinger","sequence":"first","affiliation":[{"name":"University of Washington Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A.","family":"Gross","sequence":"additional","affiliation":[{"name":"New Jersey Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trisha L.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Krause","sequence":"additional","affiliation":[{"name":"Hartford Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Martone","sequence":"additional","affiliation":[{"name":"Hospital Infections Program"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"John E.","family":"McGowan","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard L.","family":"Sweet","sequence":"additional","affiliation":[{"name":"Magee Woman's Hospital and University of Pittsburgh School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard P.","family":"Wenzel","sequence":"additional","affiliation":[{"name":"University of Iowa Hospitals and Clinics"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2015,1,2]]},"reference":[{"key":"S0195941700020683_bib033","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197908163010703"},{"key":"S0195941700020683_bib024","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/jac\/31.suppl_B.43","article-title":"Perioperative antibiotic prophylaxis and wound infection following breast surgery","volume":"31","author":"Platt","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"S0195941700020683_bib031","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1981.03310320044024"},{"key":"S0195941700020683_bib023","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/infdis\/166.3.556","article-title":"Prophylaxis against wound infection following herniorrhaphy or breast surgery","volume":"166","author":"Platt","year":"1992","journal-title":"J Infect Dis"},{"key":"S0195941700020683_bib008","first-page":"1","volume-title":"American College of Surgeons: Care of the Surgical Bxtient. Vol 2","author":"Meakins","year":"1991"},{"key":"S0195941700020683_bib026","doi-asserted-by":"crossref","first-page":"152S","DOI":"10.1016\/0002-9343(91)90361-Z","article-title":"Surgical wound infection rates by wound class, operative procedure, and patient risk index","volume":"91","author":"Culver","year":"1991","journal-title":"Am J Med"},{"key":"S0195941700020683_bib030","first-page":"219","article-title":"Re-emphasis of priorities in surgical antibiotic prophylaxis","volume":"169","author":"Galandiuk","year":"1989","journal-title":"Surg Gynecol Obstet"},{"key":"S0195941700020683_bib022","doi-asserted-by":"crossref","first-page":"S869","DOI":"10.1093\/clinids\/13.Supplement_10.S869","article-title":"Antibiotic prophylaxis in clean surgery. Peripheral vascular surgery, noncardiovascular thoracic surgery, herniorrhaphy, and mastectomy","volume":"13","author":"Hopkins","year":"1991","journal-title":"Rev Infect Dis"},{"key":"S0195941700020683_bib004","doi-asserted-by":"crossref","first-page":"S879","DOI":"10.1093\/clinids\/13.Supplement_10.S879","article-title":"Cost and benefit of perioperative antimicrobial prophylaxis: methods for economic analysis","volume":"13","author":"McGowan","year":"1991","journal-title":"Rev Infect Dis"},{"key":"S0195941700020683_bib048","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0022-5223(19)39932-5","article-title":"Cephalothin prophylaxis in cardiac valve surgery: a prospective, double-blind comparison of two-day and six-day regimens","volume":"73","author":"Goldman","year":"1977","journal-title":"J Thorac Cardio-vasc Surg"},{"key":"S0195941700020683_bib039","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1001\/jama.1983.03330340032026","article-title":"Benefit-cost analysis of antimicrobial prophylaxis in abdominal and vaginal hysterectomy","volume":"249","author":"Shapiro","year":"1983","journal-title":"JAMA"},{"key":"S0195941700020683_bib037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/infdis\/165.1.1","article-title":"Guidelines for the use of systemic glucocorticosteroids in the management of selected infections","volume":"165","author":"McGowan","year":"1992","journal-title":"J Infect Dis"},{"key":"S0195941700020683_bib047","first-page":"853","article-title":"Factors involved in antibiotic selection in elective colon and rectal surgery","volume":"104","author":"Coppa","year":"1988","journal-title":"Surgery"},{"key":"S0195941700020683_bib021","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1991.01680080130017"},{"key":"S0195941700020683_bib035","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/0002-9610(86)90228-X","article-title":"Single dose systemic antibiotic prophylaxis of surgical wound infections","volume":"152","author":"DiPiro","year":"1986","journal-title":"Am J Surg"},{"key":"S0195941700020683_bib018","first-page":"1884","article-title":"Antibiotic prophylaxis for herniorrhaphy and breast surgery","volume":"322","author":"Rutkow","year":"1984","journal-title":"N Engl JMed"},{"key":"S0195941700020683_bib029","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1001\/archsurg.1985.01390310067015","article-title":"Intraoperative serum and tissue activity of cefazolin and cefoxitin","volume":"120","author":"DiPiro","year":"1985","journal-title":"Arch Surg"},{"key":"S0195941700020683_bib027","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1001\/jama.1990.03450220085028","article-title":"Prevention of bacterial endocarditis: recommendations by the American Heart Association","volume":"264","author":"Dajani","year":"1990","journal-title":"JAMA"},{"key":"S0195941700020683_bib001","first-page":"17SS","article-title":"Nosocomial infection surveillance, 1984","volume":"35","author":"Horan","year":"1986","journal-title":"MMWR"},{"key":"S0195941700020683_bib038","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/13.Supplement_10.S821"},{"key":"S0195941700020683_bib002","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/oxfordjournals.aje.a113988","article-title":"The nationwide nosocomial infection rate: a new need for vital statistics","volume":"121","author":"Haley","year":"1985","journal-title":"Am J Epidemiol"},{"key":"S0195941700020683_bib028","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199201303260501"},{"key":"S0195941700020683_bib043","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/00000658-198801000-00020","article-title":"Antibiotic use during major head and neck surgery","volume":"207","author":"Johnson","year":"1988","journal-title":"Ann Surg"},{"key":"S0195941700020683_bib044","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1177\/106002809102500508","article-title":"Antimicrobial prophylaxis in coronary bypass surgery: a critical appraisal","volume":"25","author":"Ariano","year":"1991","journal-title":"DICP"},{"key":"S0195941700020683_bib036","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2307\/30145557","volume":"15","year":"1994","journal-title":"Infect Control Hosp Epidemiol"},{"key":"S0195941700020683_bib003","first-page":"17SS","article-title":"Nosocomial infection surveillance, 1984","volume":"35","author":"Hot-an","year":"1986","journal-title":"MMWR"},{"key":"S0195941700020683_bib019","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1056\/NEJM199006283222611","article-title":"Antibiotic prophylaxis for herniorrhaphy and breast surgery","volume":"322","author":"Byrd","year":"1990","journal-title":"N Engl J Med"},{"key":"S0195941700020683_bib020","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1991.01680080093008"},{"key":"S0195941700020683_bib040","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1128\/AAC.27.3.337","article-title":"Comparison of moxalactam and cefazolin as prophylactic antibiotics during cesarean section","volume":"27","author":"Ravbum","year":"1985","journal-title":"Antimicrob Agents Chemother"},{"key":"S0195941700020683_bib017","first-page":"1884","article-title":"Antibiotic prophylaxis for herniorrhaphy and breast surgery","volume":"322","author":"Ergina","year":"1984","journal-title":"N Engl J Med"},{"key":"S0195941700020683_bib045","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198212303072701"},{"key":"S0195941700020683_bib007","first-page":"351","volume-title":"Surgical Infectious Diseases","author":"Polk","year":"1988"},{"key":"S0195941700020683_bib010","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1993.01420130087014"},{"key":"S0195941700020683_bib014","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/BF02055549","article-title":"Preoperative bowel preparation: a survey of colon and rectal surgeons","volume":"33","author":"Solla","year":"1990","journal-title":"Dis Colon Rectum"},{"key":"S0195941700020683_bib005","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJM198610303151805","article-title":"Antimicrobial prophylaxis in surgery","volume":"315","author":"Kaiser","year":"1986","journal-title":"N Engl J Med"},{"key":"S0195941700020683_bib041","first-page":"372","article-title":"A comparative trial of cefazolin and moxalactam as prophylaxis for preventing infection after abdominal hysterectomy","volume":"66","author":"Tuomala","year":"1985","journal-title":"Obstet Gynecol"},{"key":"S0195941700020683_bib016","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1056\/NEJM199001183220303","article-title":"Perioperative antibiotic prophylaxis for herniorrhaphy and breast surgery","volume":"322","author":"Platt","year":"1990","journal-title":"N Engl J Med"},{"key":"S0195941700020683_bib013","doi-asserted-by":"crossref","first-page":"S815","DOI":"10.1093\/clinids\/13.Supplement_10.S815","article-title":"Antimicrobial prophylaxis for appendectomy and colorectal surgery","volume":"13","author":"Gorbach","year":"1991","journal-title":"Rev Infect Dis"},{"key":"S0195941700020683_bib015","first-page":"1","article-title":"National Academy of Sciences-National Research Council. Postoperative wound-infections: the influence of ultraviolet irradiation on the operating room and of various other factors","volume":"160","year":"1964","journal-title":"Ann Surg"},{"key":"S0195941700020683_bib006","first-page":"1637","volume-title":"Principles and Practice of Infectious Diseases","author":"Nichols","year":"1985"},{"key":"S0195941700020683_bib011","first-page":"483","article-title":"ASHP therapeutic guidelines on antimicrobial prophylaxis for surgery","volume":"11","year":"1992","journal-title":"Clin Pharm"},{"key":"S0195941700020683_bib025","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/oxfordjournals.aje.a113991","article-title":"Identifying patients at high risk of surgical wound infection: a simple multivariate index of patient susceptibility and wound contaminations","volume":"121","author":"Haley","year":"1985","journal-title":"Am J Epidemiol"},{"key":"S0195941700020683_bib034","doi-asserted-by":"crossref","first-page":"170S","DOI":"10.1016\/0002-9343(91)90364-4","article-title":"Analysis of risk factors for surgical wound infections following vascular surgery","volume":"91","author":"Richet","year":"1991","journal-title":"Am J Med"},{"key":"S0195941700020683_bib012","first-page":"795","article-title":"A survey of clinical trials of antibiotic prophylaxis in colon surgery: -evidence against further use of no-treatment controls","volume":"305","author":"Baum","year":"1981","journal-title":"N Enel Wed"},{"key":"S0195941700020683_bib009","first-page":"5","article-title":"Antimicrobial prophylaxis in surgery","volume":"34","year":"1992","journal-title":"Med Lett Drugs Ther"},{"key":"S0195941700020683_bib032","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/13.Supplement_10.S874"},{"key":"S0195941700020683_bib046","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/00000658-198310000-00012","article-title":"Cefoxitin versus erythromycin, neomycin, and cefazolin in colorectal operations","volume":"198","author":"Kaiser","year":"1983","journal-title":"Ann Surg"},{"key":"S0195941700020683_bib049","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-101-6-770"},{"key":"S0195941700020683_bib042","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/jac\/25.4.673","article-title":"A comparison of aztreonam\/metronidazole and cefotaxime\/metronidazole in elective colorectal surgery: antimicrobial prophylaxis must include gram-positive cover","volume":"25","author":"Morris","year":"1990","journal-title":"J Antimicrob Chemother"}],"container-title":["Infection Control & Hospital Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0195941700020683","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T10:44:28Z","timestamp":1762425868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0195941700020683\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,3]]},"references-count":49,"aliases":["10.2307\/30145558","10.2307\/30145558"],"journal-issue":{"issue":"3","published-print":{"date-parts":[[1994,3]]}},"alternative-id":["S0195941700020683"],"URL":"https:\/\/doi.org\/10.1086\/646887","relation":{},"ISSN":["0899-823X","1559-6834"],"issn-type":[{"value":"0899-823X","type":"print"},{"value":"1559-6834","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,3]]}}}